Showing results (11-20 of 87) with videos related to
Sort By:
Pageof 9
Journal of Chromatography|June 14, 1985
Sensitive liquid chromatographic method for physostigmine in biological fluids using dual-electrode electrochemical detectionR Whelpton, T MooreThe Journal of Pharmacy and Pharmacology|November 1, 1990
The binding of physostigmine to human serum albuminR Whelpton, P R HurstBiomedical Chromatography : BMC|September 1, 1989
Solid phase extraction for an improved assay of physostigmine in biological fluidsP R Hurst, R WhelptonBiopharmaceutics & Drug Disposition|April 1, 1981
Theoretical considerations in calculation of terminal phase half-times following oral doses, illustrated with model dataS H CurryCiba Foundation Symposium|January 1, 1979
Drug concentrations in neuropsychiatry. Methodological pitfalls: the influence of experimental design on resultsS H CurryJournal of Clinical Psychopharmacology|October 1, 1985
The strategy and value of neuroleptic drug monitoringS H CurryAnnals of the New York Academy of Sciences|July 21, 2001
On the relationship between plasma concentrations of drugs and outcome of stroke studies in laboratory animalsS H CurryBritish Dental Journal|October 23, 1993
Are intraligamentary injections intravascular?H Cannell, C Kerawala, K Webster, et al.Neuroscience Letters|February 16, 1996
Evidence for modulatory effects of substance P fragments (1-4) and (8-11) on endogenous dopamine outflow in rat striatal slicesS Khan, R Whelpton, A T Michael-TitusBritish Journal of Clinical Pharmacology|December 1, 1995
Binding of temoporfin to the lipoprotein fractions of human serumA T Michael-Titus, R Whelpton, Z YaqubPageof 9